주요메뉴 바로가기
본문 바로가기
하단메뉴 바로가기
통합검색
로그인
고객센터
주요메뉴
질환포커스
세계의약뉴스
국내의약뉴스
성상변경내역
약제급여기준 개정내역
제약업계 소식
메디컬포커스
컨퍼런스
CME
근골격계
남성건강
내분비대사계
면역계
비뇨기계
뇌심혈관계
종양
호흡기계
감각기관계
중추신경계
소화기계
감염계
혈액 및 조혈계
미용
기타
최근 해외학술대회의 주요 발표내용을 제공합니다.
컨퍼런스 커버리지
International Stroke Conference (ISC) 2025
05 Feb - 07 Feb, 2025, United States
DOACs for ICH survivors with atrial fibrillation? Stroke protection comes at a cost
2025-02-21
For survivors of intracerebral haemorrhage (ICH) with atrial fibrillation (AF), the use of direct oral anticoagulants (DOACs) works to prevent ischaemic stroke events, but this benefit appears to be offset by major bleeding side effects, as shown in the PRESTIGE-AF trial.
EVT-IVT combo better than EVT alone in patients with large core infarct
2025-02-21
The addition of intravenous thrombolysis (IVT) to endovascular thrombectomy (EVT) provides significant clinical benefits to patients who experienced acute ischaemic stroke (AIS) caused by large vessel occlusion (LVO) with large ischaemic infarcts (LII), as shown by the findings of a meta-analysis presented at the recent ISC 2025.
Flossing your teeth may help stave off stroke
2025-02-21
Regular flossing may do more than improve oral health ? it could help stave off stroke, suggests new research.
Long-term colchicine use helps prevent stroke, cardiac events
2025-02-21
Treatment with colchicine appears to lower the risk of stroke and major adverse cardiovascular events (MACE) when used for longer duration, according to a study presented at ISC 2025. This beneficial effect, however, is not observed among patients with shorter follow-up duration.
Oral, gut flora mainstay tied to stroke risk
2025-02-21
A study presented at ISC 2025 shows elevated levels of Streptococcus (S.) anginosus ? a type of bacteria present in the normal oral and gastrointestinal microflora ? in the mouth and gut of recent stroke survivors in Japan.
Propranolol lowers ischaemic stroke risk in women with migraine
2025-02-21
Treatment with propranolol, a non-selective beta-blocker medication widely used to prevent migraines, was associated with a significant reduction in the risk of ischaemic stroke in women with migraine, according to a preliminary study presented at ISC 2025.
T2D drug may assist in stroke prevention after minor stroke, high-risk TIA
2025-02-21
Treatment with the glucagon-like peptide-1 receptor agonist (GLP-1RA) liraglutide in Chinese patients with type 2 diabetes (T2D) has the potential to reduce the risk of stroke recurrence and improve prognosis after a minor acute ischaemic stroke or a high-risk transient ischaemic attack (TIA), as suggested in the randomized, open-label LAMP study.
1
최근 본 콘텐츠
최근 본 콘텐츠가 없습니다
관심제품
관심콘텐츠
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
